| Issue date | Document number | notification name |
| 26th, April 8 | Yakushoku Hatsu 0812 No. 1 | Regarding the revision of ministerial ordinances regarding manufacturing control and quality control standards for medical devices and in vitro diagnostic drugs, and the enactment, revision, or abolition of related ministerial ordinances and notifications in accordance with the enforcement of a law that partially amends the Pharmaceutical Affairs Law, etc.[PDF] |
| 26th, April 8 | Pharmaceutical Food and Drug Administration Bulletin 0827 No. 4 | Regarding the revision of the ministerial ordinance regarding manufacturing control and quality control standards for medical devices and in vitro diagnostic drugs in accordance with the enforcement of the law partially amending the Pharmaceutical Affairs Law, etc.[PDF] |
| 26th, April 9 | Pharmaceutical Food and Drug Administration Bulletin 0911 No. 1 | Regarding the ministerial ordinance regarding the standards for the system for conducting operations related to the manufacturing control or quality control of medical devices or in vitro diagnostic drugs[PDF] |
| 26th, April 9 | Pharmaceutical Food and Drug Administration Bulletin 0911 No. 5 | Regarding the applicability of product groups of medical devices and in vitro diagnostic drugs[PDF] |
| 26th, April 11 | Pharmaceutical Food and Drug Administration Bulletin 1119 No. 16 | Applicability of newly added generic names to product groups[PDF] |
| 26th, April 12 | Pharmaceutical Food and Drug Administration Bulletin 1202 No. 10 | Regarding the revision of “Applicability of product groups of medical devices and in vitro diagnostic drugs”[PDF] |
| 29th, April 3 | Yakusho Kanma Bulletin 0331 No. 3 | Regarding partial revisions to “Applicability of product groups of medical devices and in vitro diagnostic drugs”[PDF] |
| 29th, April 5 | Yakusho Kanma Bulletin 0526 No. 10 | Applicability of newly added generic names to product groups[PDF] |
| 26th, April 10 | Pharmaceutical Food and Drug Administration Bulletin 1024 No. 10 | Regarding the establishment of QMS investigation guidelines[PDF] |
| 26th, April 11 | Yakushoku Kanpatsu No. 1119 No. 7, Yakushoku Kansai No. 1119 No. 3 | Information regarding the handling of applications for Certificates of Compliance and QMS Compliance Assessments [PDF] |
| 26th, April 11 | Pharmaceutical Food and Drug Administration Bulletin 1121 No. 21 | Regarding selection of multiple product group classifications in QMS conformity investigation application[PDF] |
| 26th, April 11 | Pharmaceutical Food and Drug Administration Bulletin 1121 No. 25 | Questions and answers (Q&A) regarding manufacturing control and quality control standards for medical devices and in vitro diagnostic drugs[PDF] |
| 26th, April 12 | Pharmaceutical Food and Drug Administration Bulletin 1218 No. 4 | Regarding the establishment of sterilization validation standards[PDF] |
| 27th, April 3 | Pharmaceutical Food and Drug Administration Bulletin 0313 No. 8 | Questions and answers (Q&A) regarding standards for manufacturing control and quality control of medical devices and in vitro diagnostic drugs (Part 2)[PDF] |
| 27th, April 7 | Yakushoku Kanpatsu No. 0710 No. 1, Yakushoku Kanpatsu No. 0710 No. 18 | Regarding application for QMS compatibility investigation when applying for manufacturing and marketing approval for generic medical devices and improved medical devices (limited to cases where clinical trial data are not required) (re-notification)[PDF] |